Insights & Resources

Weaver’s transaction advisory team highlights a recent success guiding a client through a contentious net working capital and earn-out dispute.

Weaver supported an aviation management firm with sell-side financial and tax assistance, saving the client over $1 million in post-close adjustments.

J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.

Weaver’s Transaction Advisory Services team highlights a recent success story, guiding a client through an investment in a fast-casual restaurant.

Artificial intelligence (AI) is reshaping security, from threat detection to risk management. Explore the top three security measures for effective AI integration.

Learn about the key updates in ISO 27001:2022, including new climate change considerations and what your organization must do to stay compliant.

Within the changing landscape of educational technology, schools face new risk factors that affect students, faculty and administrators.

Explore ASC 805’s role in bringing clarity to business combinations — from fair value measurements to goodwill and beyond.

Learn how financial institutions can manage third-party risks, protect customer trust and minimize disruptions from critical service outages.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

Due diligence is a crucial step in any merger and acquisition process. This can be especially challenging for Software-as-a-Service (SaaS) companies.